• * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 2 result(s)
EBRAINS offers one of the most comprehensive platforms for sharing brain research data ranging in type as well as spatial and temporal scale. We provide the guidance and tools needed to overcome the hurdles associated with sharing data. The EBRAINS data curation service ensures that your dataset will be shared with maximum impact, visibility, reusability, and longevity, https://ebrains.eu/services/data-knowledge/share-data. Find data - the user interface of the EBRAINS Knowledge Graph - allows you to easily find data of interest. EBRAINS hosts a wide range of data types and models from different species. All data are well described and can be accessed immediately for further analysis.
Country
The Swedish Human Protein Atlas project has been set up to allow for a systematic exploration of the human proteome using Antibody-Based Proteomics. This is accomplished by combining high-throughput generation of affinity-purified antibodies with protein profiling in a multitude of tissues and cells assembled in tissue microarrays. Confocal microscopy analysis using human cell lines is performed for more detailed protein localization. The program hosts the Human Protein Atlas portal with expression profiles of human proteins in tissues and cells. The main objective of the resource centre is to produce specific antibodies to human target proteins using a high-throughput production method involving the cloning and protein expression of Protein Epitope Signature Tags (PrESTs). After purification, the antibodies are used to study expression profiles in cells and tissues and for functional analysis of the corresponding proteins in a wide range of platforms.